Logo image of RMTI

ROCKWELL MEDICAL INC (RMTI) Stock Fundamental Analysis

NASDAQ:RMTI - Nasdaq - US7743743004 - Common Stock - Currency: USD

0.992  +0.04 (+3.78%)

After market: 1.01 +0.02 (+1.81%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to RMTI. RMTI was compared to 187 industry peers in the Health Care Equipment & Supplies industry. While RMTI seems to be doing ok healthwise, there are quite some concerns on its profitability. RMTI is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

RMTI had negative earnings in the past year.
In the past year RMTI had a positive cash flow from operations.
RMTI had negative earnings in each of the past 5 years.
In the past 5 years RMTI reported 4 times negative operating cash flow.
RMTI Yearly Net Income VS EBIT VS OCF VS FCFRMTI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M

1.2 Ratios

The Return On Assets of RMTI (-0.49%) is better than 71.66% of its industry peers.
RMTI has a better Return On Equity (-0.84%) than 72.19% of its industry peers.
RMTI has a better Return On Invested Capital (1.06%) than 66.84% of its industry peers.
Industry RankSector Rank
ROA -0.49%
ROE -0.84%
ROIC 1.06%
ROA(3y)-19.01%
ROA(5y)-32.81%
ROE(3y)-57.83%
ROE(5y)-310.02%
ROIC(3y)N/A
ROIC(5y)N/A
RMTI Yearly ROA, ROE, ROICRMTI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

1.3 Margins

RMTI has a better Operating Margin (0.59%) than 64.71% of its industry peers.
RMTI has a worse Gross Margin (17.87%) than 81.28% of its industry peers.
RMTI's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 0.59%
PM (TTM) N/A
GM 17.87%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y30.04%
RMTI Yearly Profit, Operating, Gross MarginsRMTI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40

More info and screens

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), RMTI is destroying value.
Compared to 1 year ago, RMTI has more shares outstanding
The number of shares outstanding for RMTI has been increased compared to 5 years ago.
RMTI has a better debt/assets ratio than last year.
RMTI Yearly Shares OutstandingRMTI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
RMTI Yearly Total Debt VS Total AssetsRMTI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

RMTI has an Altman-Z score of -7.15. This is a bad value and indicates that RMTI is not financially healthy and even has some risk of bankruptcy.
RMTI's Altman-Z score of -7.15 is on the low side compared to the rest of the industry. RMTI is outperformed by 73.80% of its industry peers.
The Debt to FCF ratio of RMTI is 4.63, which is a neutral value as it means it would take RMTI, 4.63 years of fcf income to pay off all of its debts.
RMTI's Debt to FCF ratio of 4.63 is amongst the best of the industry. RMTI outperforms 82.35% of its industry peers.
A Debt/Equity ratio of 0.30 indicates that RMTI is not too dependend on debt financing.
RMTI has a Debt to Equity ratio (0.30) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 4.63
Altman-Z -7.15
ROIC/WACC0.13
WACC8.29%
RMTI Yearly LT Debt VS Equity VS FCFRMTI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

2.3 Liquidity

A Current Ratio of 2.95 indicates that RMTI has no problem at all paying its short term obligations.
RMTI's Current ratio of 2.95 is in line compared to the rest of the industry. RMTI outperforms 56.15% of its industry peers.
A Quick Ratio of 2.50 indicates that RMTI has no problem at all paying its short term obligations.
RMTI has a Quick ratio (2.50) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.95
Quick Ratio 2.5
RMTI Yearly Current Assets VS Current LiabilitesRMTI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 99.72% over the past year.
Looking at the last year, RMTI shows a quite strong growth in Revenue. The Revenue has grown by 12.82% in the last year.
RMTI shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.61% yearly.
EPS 1Y (TTM)99.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
Revenue 1Y (TTM)12.82%
Revenue growth 3Y17.9%
Revenue growth 5Y10.61%
Sales Q2Q%-16.59%

3.2 Future

The Earnings Per Share is expected to decrease by -169.92% on average over the next years. This is quite bad
Based on estimates for the next years, RMTI will show a quite strong growth in Revenue. The Revenue will grow by 13.83% on average per year.
EPS Next Y-895.71%
EPS Next 2Y-169.92%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-32.1%
Revenue Next 2Y-13.12%
Revenue Next 3Y13.83%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
RMTI Yearly Revenue VS EstimatesRMTI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
RMTI Yearly EPS VS EstimatesRMTI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -2 -4 -6

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

RMTI is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RMTI Price Earnings VS Forward Price EarningsRMTI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

RMTI's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. RMTI is cheaper than 95.72% of the companies in the same industry.
90.37% of the companies in the same industry are more expensive than RMTI, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 15.69
EV/EBITDA 7.04
RMTI Per share dataRMTI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

RMTI's earnings are expected to decrease with -169.92% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-169.92%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for RMTI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ROCKWELL MEDICAL INC

NASDAQ:RMTI (8/4/2025, 8:00:01 PM)

After market: 1.01 +0.02 (+1.81%)

0.992

+0.04 (+3.78%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-12 2025-05-12/bmo
Earnings (Next)08-14 2025-08-14
Inst Owners20.56%
Inst Owner Change1.08%
Ins Owners4.45%
Ins Owner Change7.69%
Market Cap33.90M
Analysts82.5
Price Target4.08 (311.29%)
Short Float %0.52%
Short Ratio0.5
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-88.24%
Min EPS beat(2)-198.04%
Max EPS beat(2)21.57%
EPS beat(4)3
Avg EPS beat(4)84.73%
Min EPS beat(4)-198.04%
Max EPS beat(4)390.2%
EPS beat(8)5
Avg EPS beat(8)38.68%
EPS beat(12)9
Avg EPS beat(12)37.59%
EPS beat(16)11
Avg EPS beat(16)34.01%
Revenue beat(2)2
Avg Revenue beat(2)4.22%
Min Revenue beat(2)2.23%
Max Revenue beat(2)6.2%
Revenue beat(4)4
Avg Revenue beat(4)5.92%
Min Revenue beat(4)2.23%
Max Revenue beat(4)10.49%
Revenue beat(8)6
Avg Revenue beat(8)2.74%
Revenue beat(12)9
Avg Revenue beat(12)3.54%
Revenue beat(16)9
Avg Revenue beat(16)-1.29%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-25%
EPS NY rev (1m)0%
EPS NY rev (3m)-24.24%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.62%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.2%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.35
P/FCF 15.69
P/OCF 10.95
P/B 1.08
P/tB 1.65
EV/EBITDA 7.04
EPS(TTM)0
EYN/A
EPS(NY)-0.15
Fwd EYN/A
FCF(TTM)0.06
FCFY6.37%
OCF(TTM)0.09
OCFY9.13%
SpS2.86
BVpS0.92
TBVpS0.6
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.49%
ROE -0.84%
ROCE 1.34%
ROIC 1.06%
ROICexc 1.77%
ROICexgc 3.12%
OM 0.59%
PM (TTM) N/A
GM 17.87%
FCFM 2.21%
ROA(3y)-19.01%
ROA(5y)-32.81%
ROE(3y)-57.83%
ROE(5y)-310.02%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y30.04%
F-Score7
Asset Turnover1.81
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 4.63
Debt/EBITDA 3.42
Cap/Depr 43.01%
Cap/Sales 0.96%
Interest Coverage 0.71
Cash Conversion 112.71%
Profit Quality N/A
Current Ratio 2.95
Quick Ratio 2.5
Altman-Z -7.15
F-Score7
WACC8.29%
ROIC/WACC0.13
Cap/Depr(3y)323.45%
Cap/Depr(5y)234.89%
Cap/Sales(3y)5.5%
Cap/Sales(5y)3.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)99.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
EPS Next Y-895.71%
EPS Next 2Y-169.92%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)12.82%
Revenue growth 3Y17.9%
Revenue growth 5Y10.61%
Sales Q2Q%-16.59%
Revenue Next Year-32.1%
Revenue Next 2Y-13.12%
Revenue Next 3Y13.83%
Revenue Next 5YN/A
EBIT growth 1Y108.71%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-246.39%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y118.18%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y126.96%
OCF growth 3YN/A
OCF growth 5YN/A